Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$33.8M Sell
1,550,825
-54,400
-3% -$1.24M 0.58% 57
2017
Q1
$34M Buy
1,605,225
+416,611
+35% +$9.54M 0.61% 53
2016
Q4
$29.7M Sell
1,188,614
-344,372
-22% -$8.83M 0.58% 55
2016
Q3
$43.2M Buy
1,532,986
+197,343
+15% +$5.51M 0.81% 43
2016
Q2
$35.8M Buy
1,335,643
+405,469
+44% +$11.4M 0.71% 50
2016
Q1
$26.9M Buy
930,174
+472,794
+103% +$12.6M 0.54% 59
2015
Q4
$12.8M Buy
457,380
+418,689
+1,082% +$12.1M 0.25% 83
2015
Q3
$1.05M Sell
38,691
-704
-2% -$19K 0.02% 281
2015
Q2
$938K Buy
39,395
+330
+0.8% +$8.32K 0.02% 320
2015
Q1
$949K Buy
+39,065
New +$836K 0.02% 311

Other funds holding SABR

Geneva Advisors's SABR Position: Q2 2017 in Review

Geneva Advisors reduced its Sabre (SABR) stake by 3.4% in Q2 2017, selling an estimated $1.24M and leaving 1,550,825 shares worth $33.8M. The position accounts for 0.58% of the portfolio, ranked #57.

Geneva Advisors first reported a position in SABR in Q1 2015 and has held it in 10 quarters since. The position peaked at $43.2M in Q3 2016. 298 funds tracked by Wall St. Rank hold SABR as of Q2 2017.

  • Geneva Advisors held 1,550,825 shares of Sabre worth $33.8M as of Q2 2017.
  • Geneva Advisors sold 54,400 Sabre shares in Q2 2017, an estimated $1.24M.
  • Sabre made up 0.58% of Geneva Advisors's portfolio in Q2 2017, its #57 holding.
  • Geneva Advisors first reported a position in Sabre in Q1 2015 and has held it in 10 quarters since.
  • Geneva Advisors's Sabre position peaked at $43.2M in Q3 2016.
  • 298 funds tracked by Wall St. Rank held Sabre as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.